“Latest Stem Cells News”

Alex Normandin, 26, of Montreal, Canada has been cured of his Multiple Sclerosis following the implantation of his own Adult Stem Cells. The stem cell therapy was done in conjunction with a research program in Ottawa with Dr. Mark Freedman.

A medical student, Alex was diagnosed with multiple sclerosis more than 2 years ago and was distressed to learn that he had the aggressive form of MS and was on track to be in a wheelchair in a matter of months.

Process of Stem Cells for Multiple Sclerosis in Canada

Luckily, he was accepted into Dr. Freedman’s stem cell research program at Ottawa General Hospital. In this stem cell program, the patient is first given chemotherapy to kill off the immune system. Then, the stem cell transplant takes place to “reboot” the immune system.

From the stem cell article:

Normandin became patient 19. His transplant took place in December 2008. It worked.

Not only does the disease appear to have stopped its progression, but Normandin says he feels his co-ordination and strength improving.

Normandin is buoyed by the treatment’s eight-year track record — none of the 24 patients have suffered a relapse or a brain lesion. (The article fails to mention the one patient who died from the chemo)

Stem Cell Therapy in China Quote Remembered

Readers of this blog may remember Dr. Freedman from this Multiple Sclerosis Stem Cell post in which he commented on stem cell therapy in China:

Dr. Freedman is concerned that patients are forking over large amounts of money for unproven treatments like this, especially when there is no follow-up care or monitoring when they get home.

“It’s dangerous in the wrong hands,” he said. “The only reason these places could be in existence is to take people’s money and offer them something that’s unproven.”

I called that the “Most Hypocritical Statement So Far in 2009″ then, and I will stick to that for the following reasons:

1. Chemotherapy is dangerous.  1 of Dr. Freedman’s patients died while receiving it before the stem cell transplant- to call another treatment dangerous (which doesn’t use chemo, by the way) is hypocritical.
2. He says the therapies are unproven and only in existence to take people’s money-  however, in this article- it is revealed not only is his own treatment unproven, but it also is not free, in fact, far from free- “The trial procedure costs would be about $50,000 to $60,000 per patient.”  (A reader has since wrote in and says the Canadian Government pays for this treatment)
   

Actually that cost is more than other stem cell therapies in Costa Rica and China that we have covered in here (both are around $25-30,000) and do NOT use chemo.

So for those people who say that stem cell therapy overseas is very expensive– just look at Canada, or for that matter, look at Dr. Richard Burt’s multiple sclerosis study at Northwestern University in Chicago.  The cost for one multiple sclerosis patient is $90,000

I’m directing  this at critics who always point out that overseas stem cell therapies are expensive and dangerous rather than pointing out the “arrogance” of Dr. Freedman, who as far as I can tell is truly helping Multiple Sclerosis patients although he probably shouldn’t be opening his mouth about other stem cell treatments.

Stem Cell Treatment By The People, For The People

And yes, all of  these stem cell treatments in Canada, USA, Costa Rica, and China are “unproven” in the eyes of the medical world and the New England Journal of Medicine, although they all are proven in the eyes of the patients who receive the Adult Stem Cells whether they are in the form of umbilical cord stem cells (China), mixture of stem cells from the patient’s fat and cord blood stem cells(Costa Rica) and/or Adult Stem Cells given in the form of a stem cell transplant after chemotherapy (Canada, USA).   They all seem to work most of the time FOR THE PATIENTS NOW and that is what is important. Making Multiple Sclerosis patients wait for 10 years or so for the endless cycle of clinical trials in the US and Canada to end just so their doctors can see the words “proven” in a study is a travesty.

The Emergence of the Internet and Self Directed Healthcare

We can ask Jason Upshaw and friends about stem cell therapy in Costa Rica. Or, we can ask Betty Helm about how stem cell therapy in China worked for her MS. Thanks to the wonders of the internet, patients now have a bigger say and more access to information than ever before.

Dr. William Davis at the Heart Scan Blog has a great post on how health care is changing. Much like stockbrokers have disappeared due to online companies like E-trade and Ameritrade, patients can now take a more self directed approach to their health thanks to the internet.

original post by Don Margolis

Incoming search terms:

A stem cell research study showing that Adult Stem Cells taken from a patient’s fat and then implanted back into that patient, helps improve their Multiple Sclerosis. The research study documented 3 case studies of Multiple Sclerosis patients.

Case Studies of Multiple Sclerosis Patients Implanted with Fat Stem Cells

Case Study #1- 50 year old man with Relapse-remitting MS:

Before the Stem Cell Therapy:

• Multiple Seizures
• Sexual Dysfunction
• Significant Memory Loss
• Taking Multiple Medications- Solu-Medrol, Baclofen,
  Provigil, Tegretol, Trileptal, Tysabri, Vitamins, Omega-3 and Zanaflex

After the Fat Stem Cells were implanted:

• No more seizures
• Improved Sexual Function
• Improved Memory
• OFF ALL MEDICATIONS

Case Study #2- 32 year old man with Relapsing-remitting MS

This patient reported after the stem cell therapy and treatment that he now has:

1. Better Balance and Coordination
2. His Depression is gone
3. Significantly improved overall condition

Incoming search terms:

After seeing the fastest development worldwide in stem cell research during the past 10 years, China is “on the verge of achieving a breakthrough”, says a top scientist in the field.
Zhou Qi, chief scientist with the stem cell research project at the Chinese Academy of Sciences (CAS), spoke after the academy chose his area of expertise for significant attention.

He said Chinese scientists are expecting a major scientific breakthrough to be made within the next decade.
“We are now close to the day when we will be able to hail a breakthrough in this important technology,” Zhou told China Daily during an exclusive interview.

He said China has already succeeded in creating a “stem cell line up to clinical standards“, which signifies a major stride toward clinical treatment.
“China needs five to 10 years to shift from basic research to clinical application and another 10 years to realize large-scale clinical application,” he said.

“If there are any science projects that could win China a Nobel Prize during the next 10 years, the most likely candidate is its stem cell research.”
Going forward, the priority will be to focus on stem cell regulation, core mechanisms for stem-cell therapies and standardized applications of stem cells, Zhou said.

Incoming search terms:

“The tracheal team at Great Ormond Street Hospital is delighted that Ciaran is going home after his tracheal transplant. He is a wonderful boy who has become a great friend to us all, and he and his infinitely patient family have charmed us all. Ciaran has become our local iPad expert, and we will miss his advice. His recovery has been complicated, as one might expect for a new procedure, and we have kept him under close surveillance, hence the length of time he has been here. It is wonderful to see him active, smiling and breathing normally. We are very proud of him!

“Ciaran will continue to need regular follow up by us. This is so we can both make sure he is ok, and also learn what to expect for the next patient who needs this innovative therapy. The treatment offers hope to many whose major airways were previously considered untreatable or irreplaceable. We will continue to work with our colleagues in regenerative medicine throughout the world to ensure we can continue to improve both the science and treatment options.”

from http://www.ich.ucl.ac.uk/pressoffice/pressrelease_00852

Incoming search terms:

Joseph Wagner sees most cell-therapy companies offering little more than a bag of cells.
His company will give the bag a little direction.

Cell Targeting is developing technology that can point stem cell therapies to specific areas of the body. Among the many challenges in cell therapy is direction: not enough of the stem cells are getting to the tissues that needs treatment (…)

Currently a stem cell therapy can help different parts of the body. That attracts more customers, but doesn’t do much when the company wants to differentiate its product and charge a different price.

A stem cell therapy tweaked by Cell Targeting can become unique because it can be directed to different areas of the body to treat different afflictions, Wagner said.

“We make them distinct by our delivery,” Wagner said. “We have the ability to make those bags of cells into unique cell-therapy products.”

Cell Targeting’s product is a peptide, a tiny piece of protein, that coats stem cells and guides them to damaged tissue. The coating peels away like paint after it gets to its target and allows the therapy to do its work (…)

But Cell Targeting’s biggest competitor may be science itself and the research underway to better understand how stem cells work. It’s likely that stem cells on their own can find their way “home” to specific tissues, Gerson said.

“We just don’t know what those Velcro connections are,” Gerson said.

Wagner said the idea that stem cells head home is a bit of “voodoo.” Only a single-digit percentage of cells return to their point of origin — and there’s no evidence they return in a larger percentage to damaged tissues, he said. Also, Wagner pointed out that in many cases, cell therapy companies don’t want stem cells to go “home” but instead to another tissue that the stem cell can also heal (…)

from http://www.medcitynews.com/index.php/2009/09/cell-targeting-ready-to-bring-purpose-to-stem-cell-therapy/

Recent stem cell research studies using Adult Stem Cells to treat heart diseases such as congestive heart failure and heart attacks have made the news recently.  And on the surface, these adult stem cell success stories of heart attack victims making amazing recoveries in these research clinical trials is wonderful news indeed.

New Research Trials for Heart Attack Victims

For example, at the Texas Heart Institute, John Hartman who had suffered a heart attack recently had his own stem cells implanted into his heart muscle in a new stem cell research trial.

From the stem cell article:

Dr. Jim Willerson President, Texas Heart Institute, said, “We think the improvement we see is largely from the blood flow increase salvaging the cells that are reversibly injured, allowing them to function normally.”

“That reflects in the patient being able to do better, walk further, breathe better,” said Dr. Emerson Perin St Luke’s, THI Cardiologist.

Stem Cell Trial for Congestive Heart Failure

Also, in another stem cell research trial at Vanderbilt, an unnamed 65 year old congestive heart failure patient was treated using his own Adult Stem Cells again.   Dr. David Zhao, director of the cath lab there said “The patients who stand to benefit from this approach include those whose coronary arteries are so diseased that nothing else could be done,”

What About Heart Disease Patients Who Can’t Get Adult Stem Cells?

However, the headlines don’t mention the millions who are suffering and dying after having heart attacks (1.25 million per year in the United States) and are in congestive heart failure and don’t have the opportunity to receive adult stem cell treatment because the FDA has classified a patient’s own stem cells as a drug- thus slowing down progress and starving heart patients of a “drug” with no side effects or ethical issues and only has upside.

For every Barry Brown or Kenneth Milles, heart attack victims who were lucky enough to get into a US stem cell research clinical trial using their own stem cells, there are millions of heart disease patients who do not have that opportunity. And for that, we have the FDA to blame.

And that is only addressing adult stem cell therapy for heart disease………what about the hundreds of other conditions that can be helped or improved by Adult Stem Cells?

Sad.

For more information on clinical research trials in the United States, go to the Clinical Trials website – www.clinicaltrials.gov